NHS will not fund new drug to slow Alzheimer’s
A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS in England, the drugs spending watchdog says. Donanemab was hailed as a turning point in the disease last year. But the National Institute ...
Eli Lilly Alzheimer’s Drug Rejected for NHS Use in England
Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the drug cost regulator deemed its benefits were too small to justify the price.
New Alzheimer’s drugs should be available on NHS, says patient’s wife
A wife whose husband will not be eligible for new Alzheimer’s drugs has implored health leaders to ensure that others like him will be able to access treatments. New disease-modifying Alzheimer’s drugs work best when they are given to patients in the early stages of disease.
Alzheimer’s wonder drug blocked on NHS over cost
The most effective drug for Alzheimer’s has been blocked for use on the NHS. Regulators have declared the new treatment for the disease safe for use but the rationing body has immediately ruled that it is too expensive for NHS patients.
Alzheimer's Society responds to approval of new Alzheimer's drug
The Alzheimer's Society Cymru has responded to the approval of a new Alzheimer's treatment. The Medicines and Healthcare products Regulatory Agency (MHRA) announced on Wednesday, October 23, that it has approved the drug donanemab.
Alzheimer's 'wonder drug' Donanemab blocked for use on NHS over cost concerns
Alzheimer's 'wonder drug' Donanemab blocked for use on NHS over cost concerns - Campaigners say decision is ‘frustrating setback’ for people living with disease
'Incredibly disappointing': Pioneering Alzheimer’s drug blocked for widespread NHS use in England
A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending watchdog said it “does not currently demonstrate value for the NHS”. The news comes as the UK’s medicines regulator said donanemab could be licensed for use in the UK.
Planet Normal: People have realised the NHS is not a religion
We pay for a health service which comes in the bottom two of 18 developed countries for almost all outcomes, including common ...
The Harvard Crimson15h
Decades-Long NHS Research Jeopardized by Funding Cuts
The NHS is one of the largest studies of women’s risk factors for major chronic diseases. Initially designed to study the ...
FM pushes for significant NHS cash boost in budget
The first minister of Wales has pushed for a "significant" boost to NHS finances to be announce in the UK government's Autumn ...
Mum calls for NHS rule change on free IVF - even if you've got children
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Labour's NHS consultation trolled with joke ideas
The British public did not fail to disappoint after the government launched a public consultation to shape up the NHS.
New NHS emergency hospital will be bigger
A new hospital for Norfolk will be larger than the current one and built on the site of the present hospital car park, an NHS ...
What the changes to the new NHS app could mean for you
Every NHS patient will carry their medical records with them in a ‘patient passport’ in the NHS app under new plans unveiled ...
New data bill to loosen red tape for businesses and NHS
Britain's tech secretary said the new data bill will help boost the UK’s economy by relieving people from "unnecessary admin" ...
NHS cancer treatment wait times worst on record since 2010
Wait times for cancer treatment on the NHS are at their worst level on record since 2010, according to the health service’s ...